WSD-0922

DB17170InvestigationalSmall molecule

WSD-0922: Overview.

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Formula / weight: C₂₃H₂₁F₃N₄O₂ · 442.442 g/mol (avg)
Also known as: (r)-6-((3,3-difluoro-1-methylpiperidin-4-yl)oxy)-n-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine-
Code names: WSD-0922

Resolves to

Compound

Structure

InChIKeyRIHUDRGMCALEAK-HXUWFJFHSA-NSMILESCOC1=CC2=NC=NC(NC3=CC=CC(C#C)=C3F)=C2C=C1O[C@@H]1CCN(C)CC1(F)F

Targets

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with WSD-0922, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.